Characterization of a ligand for receptor protein-tyrosine kinase HTK expressed in immature hematopoietic cells - PubMed (original) (raw)
. 1996 Aug 15;13(4):813-22.
R Serizawa, T Inada, A Iwama, A Itoh, C Kato, Y Shimizu, F Shinkai, R Shimizu, S Kondo, M Ohno, T Suda
Affiliations
- PMID: 8761303
Characterization of a ligand for receptor protein-tyrosine kinase HTK expressed in immature hematopoietic cells
S Sakano et al. Oncogene. 1996.
Abstract
HTK is a receptor tyrosine kinase that belongs to the Eph subfamily. An extensive screening using BIAcore system revealed that a colon cancer cell line, C-1, expressed the ligand for HTK. From the conditioned medium of C-1 cells, a soluble form of ligand was purified by receptor affinity chromatography, and the isolation of full-length cDNA revealed that this ligand is identical to the human HTK ligand (HTKL) previously reported. HTK receptor tyrosine phosphorylation was induced by membrane-bound or clustered soluble HTKL but not by unclustered soluble HTKL, indicating that HTKL requires cell-to-cell interaction for receptor activation. Binding analysis demonstrated that HTKL binds to HTK with a much higher affinity (Kd: 1.23 nM) than the other transmembrane-type ligand for Eph family, LERK-2/ELKL (Kd: 135 nM). The expression of HTK in cord blood cells was upregulated after the culture in the presence of stem cell factor. Clustered soluble HTKL stimulated the proliferation of sorted HTK+ cord blood cells and a hematopoietic cell line, UT-7/EPO from which HTK was isolated. These findings suggest the involvement of HTK-HTKL system in the proliferation of HTK+ hematopoietic progenitor cells in the hematopoietic environment.
Similar articles
- Bidirectional signalling through the EPH-family receptor Nuk and its transmembrane ligands.
Holland SJ, Gale NW, Mbamalu G, Yancopoulos GD, Henkemeyer M, Pawson T. Holland SJ, et al. Nature. 1996 Oct 24;383(6602):722-5. doi: 10.1038/383722a0. Nature. 1996. PMID: 8878483 - Expression of receptor tyrosine kinase HTK (hepatoma transmembrane kinase) and HTK ligand by human leukemia-lymphoma cell lines.
Steube KG, Meyer C, Habig S, Uphoff CC, Drexler HG. Steube KG, et al. Leuk Lymphoma. 1999 Apr;33(3-4):371-6. doi: 10.3109/10428199909058438. Leuk Lymphoma. 1999. PMID: 10221518 - Molecular cloning of a ligand for the EPH-related receptor protein-tyrosine kinase Htk.
Bennett BD, Zeigler FC, Gu Q, Fendly B, Goddard AD, Gillett N, Matthews W. Bennett BD, et al. Proc Natl Acad Sci U S A. 1995 Mar 14;92(6):1866-70. doi: 10.1073/pnas.92.6.1866. Proc Natl Acad Sci U S A. 1995. PMID: 7534404 Free PMC article. - LERK-7: a ligand of the Eph-related kinases is developmentally regulated in the brain.
Kozlosky CJ, VandenBos T, Park L, Cerretti DP, Carpenter MK. Kozlosky CJ, et al. Cytokine. 1997 Aug;9(8):540-9. doi: 10.1006/cyto.1997.0199. Cytokine. 1997. PMID: 9245480 - Roles of Eph receptors and ephrins in segmental patterning.
Xu Q, Mellitzer G, Wilkinson DG. Xu Q, et al. Philos Trans R Soc Lond B Biol Sci. 2000 Jul 29;355(1399):993-1002. doi: 10.1098/rstb.2000.0635. Philos Trans R Soc Lond B Biol Sci. 2000. PMID: 11128993 Free PMC article. Review.
Cited by
- EPH/Ephrin Signaling in Normal Hematopoiesis and Hematologic Malignancies: Deciphering Their Intricate Role and Unraveling Possible New Therapeutic Targets.
Stergiou IE, Papadakos SP, Karyda A, Tsitsilonis OE, Dimopoulos MA, Theocharis S. Stergiou IE, et al. Cancers (Basel). 2023 Aug 4;15(15):3963. doi: 10.3390/cancers15153963. Cancers (Basel). 2023. PMID: 37568780 Free PMC article. Review. - Mutations in EPHB4 cause human venous valve aplasia.
Lyons O, Walker J, Seet C, Ikram M, Kuchta A, Arnold A, Hernández-Vásquez M, Frye M, Vizcay-Barrena G, Fleck RA, Patel AS, Padayachee S, Mortimer P, Jeffery S, Berland S, Mansour S, Ostergaard P, Makinen T, Modarai B, Saha P, Smith A. Lyons O, et al. JCI Insight. 2021 Sep 22;6(18):e140952. doi: 10.1172/jci.insight.140952. JCI Insight. 2021. PMID: 34403370 Free PMC article. - EphrinB2-EphB4-RASA1 Signaling in Human Cerebrovascular Development and Disease.
Zeng X, Hunt A, Jin SC, Duran D, Gaillard J, Kahle KT. Zeng X, et al. Trends Mol Med. 2019 Apr;25(4):265-286. doi: 10.1016/j.molmed.2019.01.009. Epub 2019 Feb 25. Trends Mol Med. 2019. PMID: 30819650 Free PMC article. Review. - Overexpression of erythropoietin-producing hepatocyte receptor B4 and ephrin-B2 is associated with estrogen receptor expression in endometrial adenocarcinoma.
Dong LD, Cheng XL, Zhou L, Huang Q, Li JC, Yi CJ. Dong LD, et al. Oncol Lett. 2017 Apr;13(4):2109-2114. doi: 10.3892/ol.2017.5698. Epub 2017 Feb 8. Oncol Lett. 2017. PMID: 28454369 Free PMC article. - Ephrin Ligands and Eph Receptors Show Regionally Restricted Expression in the Developing Palate and Tongue.
Xavier GM, Miletich I, Cobourne MT. Xavier GM, et al. Front Physiol. 2016 Feb 23;7:60. doi: 10.3389/fphys.2016.00060. eCollection 2016. Front Physiol. 2016. PMID: 26941654 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources
Research Materials
Miscellaneous